Skip to content

A dermatological study to evaluate hair thickening spray (Containing Bhringraj and Shikakai) on healthy volunteers

A single centre prospective dermatological study to evaluate parameters on hair growth, volume hair thickness with hair thickening spray (Bhringraj and Shikakai) in healthy volunteers

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/05/042565
Enrollment
50
Registered
2022-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Mountain Valley Springs India Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy subjects (no infectious and evaluative pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory check-up) Indian Male/Female subjects. Hair & scalp is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar etc) Between 18 to 65 years of age, with normal Hair condition. Written informed consent signed by the subject in line with applicable regulation of country.

Exclusion criteria

Exclusion criteria: Having refused to give her consent by not signing the consent form. Taking part in another study liable to interfere with this study. Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis). Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products. Having cutaneous hypersensitivity. Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only hair and scalp cleaned with water is accepted).

Design outcomes

Primary

MeasureTime frame
Evaluation will include assessment of local adverse events of redness, itching, rashes and burning sensations and any other local side effect and will be categorized non serious (based on severity grades, patterns, and causality) and serious adverse events. There will be two types of assessment, subject self-assessment, and dermatological evaluation by study investigatorTimepoint: Subjects will assessed at 30 minutes, 15 days and 30 days after test product application

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactMr Nishant Singh

Mountain Valley Springs India Pvt. Ltd.

nishant.singh@forestessentialsindia.com08860800289

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026